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Withania somnifera (Ashawagandha) is very revered herb of the Indian Ayurvedic system of medicine as a 
Rasayana (tonic). It is used for various kinds of disease processes and specially as a nervine tonic. Considering these facts 
many scientific studies were carried out and its adaptogenic / anti-stress activities were studied in detail. In experimental 
models it increases the stamina of rats during swimming endurance test and prevented adrenal gland changes of ascorbic acid 
and cortisol content produce by swimming stress. Pretreatment with Withania somnifera (WS) showed significance protection 
against stress induced gastric ulcers. WS have anti-tumor effect on Chinese Hamster Ovary (CHO) cell carcinoma. It was also 
found effective against urethane induced lung-adenoma in mice. In some cases of uterine fibroids, dermatosarcoma, long 
term treatment with WS controlled the condition. It has a Cognition Promoting Effect and was useful in children with 
memory deficit and in old age people loss of memory. It was also found useful in neurodegenerative diseases such as 
Parkinson’s, Huntington’s and Alzeimer’s diseases. It has GABA mimetic effect and was shown to promote formation of 
dendrites. It has anxiolytic effect and improves energy levels and mitochondrial health. It is an anti-inflammatory and anti-
arthritic agent and was found useful in clinical cases of Rheumatoid and Osteoarthritis. Large scale studies are needed to 
prove its clinical efficacy in stress related disorders, neuronal disorders and cancers. 
 






Ashwagandha (Withania somnifera, fam. Solanaceae) is commonly known as “Indian Winter cherry” or “Indian 
Ginseng”. It is one of the most important herb of Ayurveda (the traditional system of medicine in India) used for millennia as a 
Rasayana for its wide ranging health benefits. Rasayana is described as an herbal or metallic preparation that promotes a 
youthful state of physical and mental health and expands happiness. These types of remedies are given to small children as 
tonics, and are also taken by the middle-aged and elderly to increase longevity. Among the ayurvedic Rasayana herbs, 
Ashwagandha holds the most prominent place. It is known as “Sattvic Kapha Rasayana” Herb (Changhadi, 1938). Most of the 
Rasayana herbs are adaptogen / anti-stress agents.  
Ashwagandha is commonly available as a churna, a fine sieved powder that can be mixed with water, ghee (clarified 
butter) or honey. It enhances the function of the brain and nervous system and improves the memory.  It improves the function 
of the reproductive system promoting a healthy sexual and reproductive balance. Being a powerful adaptogen, it enhances the 
body’s resilience to stress. Ashwagandha improves the body’s defense against disease by improving the cell-mediated 




iThe biologically active chemical constituents of Withania somnifera (WS) include alkaloids (isopelletierine, 
anaferine, cuseohygrine, anahygrine, etc.), steroidal lactones (withanolides, withaferins) and saponins (Mishra, 2000 et al., 
2000). Sitoindosides and acylsterylglucosides in Ashwagandha are anti-stress agents. Active principles of Ashwagandha, for 
instance the sitoindosides VII–X and Withaferin-A, have been shown to have significant anti-stress activity against acute 
models of experimental stress (Bhattacharya et al., 1987). Many of its constituents support immunomodulatory actions (Ghosal 
et al., 1989). The aerial parts of Withania somnifera yielded 5-dehydroxy withanolide-R and withasomniferin-A (Atta-ur-
Rahman et al., 1991). 
 
Classical Uses of Ashwagandha 
 
Ayurveda, the traditional system of medicine practiced in India can be traced back to 6000 BC (Charak Samhita, 
1949). For most of these 6000 years Ashwagandha has been used as a Rasayana. The root of Ashwagandha is regarded as 
tonic, aphrodisiac, narcotic, diuretic, anthelmintic, astringent, thermogenic and stimulant. The root smells like horse 
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(“ashwa”), that is why it is called Ashwagandha (on consuming it gives the power of a horse). It is commonly used in 
emaciation of children (when given with milk, it is the best tonic for children), debility from old age, rheumatism, vitiated 
conditions of vata, leucoderma, constipation, insomnia, nervous breakdown, goiter etc. (Sharma, 1999). The paste formed 
when roots are crushed with water is applied to reduce the inflammation at the joints (Bhandari, 1970). It is also locally applied 
in carbuncles, ulcers and painful swellings (Kritikar and Basu, 1935). The root in combination with other drugs is prescribed 
for snake venom as well as in scorpion-sting. It also helps in leucorrhoea, boils, pimples, flatulent colic, worms and piles 
(Misra, 2004). The Nagori Ashwagandha is the supreme among all Ashwagandha varieties. Maximum benefit appears when 
fresh Ashwagandha powder is used (Singh, 1983).  
The leaves are bitter and are recommended in fever, painful swellings. The flowers are astringent, depurative, 
diuretic and aphrodisiac. The seeds are anthelmintic and combined with astringent and rock salt remove white spots from the 
cornea. Ashwagandharishta prepared from it is used in hysteria, anxiety, memory loss, syncope, etc. It also acts as a stimulant 
and increases the sperm count (Sharma, 1938). 
 
Scientific Studies on Ashwagandha  
Adaptogenic / Anti-stress effect 
 
Aswagandha is compared well with Eleutherococcus senticosus (Siberian Ginseng) and Panax Ginseng (Chinese / Korean 
Ginseng) in its adaptogenic properties, and hence it is popularly known as Indian Ginseng (Singh et al., 2010). The extensive 
studies on the biological model of animals for the adaptogenic / anti-stress properties of Ashwagandha (Abbas and Singh, 
2006; Kalsi et al., 1987; Singh et al., 1976, 1977, 1981, 1982, 1993a, 1993b, 2003; (Singh, 1995a, 1995b, 2006, 2008) have 
shown it to be effective in increasing the stamina (physical endurance) and preventing stress induced gastric ulcer, carbon 
tetrachloride (CCl4) induced hepatotoxicity and mortality. Ashawagandha have similar anti-stress activity in rats (Archana & 
Namasivayam, 1999). An aqueous suspension of Ashwagandha root was used at 100 mg/kg/oral dosage.  The results indicate a 
significant increase in the plasma corticosterone level, phagocytic index and avidity index in rats subjected to cold swimming 
stress. In the rats pretreated with the drug, these parameters were near control values and an increase in the swimming time was 
observed.  These results indicate that Withania somnifera used in the crude form is a potent anti-stress agent. The results of 
above studies lend support to the hypothesis of tonics, vitalizers and rejuvenators of Ayurveda which indicate clinical use of 
Withania somnifera in the prevention and treatment of many stress induced diseases like arteriosclerosis, premature ageing, 
arthritis, diabetes, hypertension and malignancy (Singh, 1986, 2005; Singh and Misra, 1993). 
 
i. Effect on swimming performance 
 
Ashwagandha was shown to increase swimming performance in rats as judged by increase in swimming time during 
physical endurance test. Ashwagandha’s  antistress properties have been investigated in all these studies using adult rats were 
carried out by swimming endurance stress test. Ashwagandha treated animals showed a significant increase in the duration of 
swimming time as compared to control. The control group of mice swam for a mean time of 385 minutes, whereas the drug-
treated animals continued to swim for a mean duration of 740 minutes. Thus, the swimming time was approximately doubled 
after Withania somnifera (WS) treatment. 
 
ii. Effect on cortisol and ascorbic acid contents of adrenals 
 
The cortisol content of adrenals was reduced significantly in animals subjected to 5 h constant swimming as 
compared to non-swimmer group. Pretreatment with WS prevented reduction of the cortisol content of adrenals. The ascorbic 
acid content was also reduced significantly after 5 h of swimming as compared to the animal of non-swimmer group. 
Pretreatment with WS prevent reduction in ascorbic acid content which occurs after swimming stress. Thus, Withania 
somnifera treatment prevents, decrease of adrenal cortisol and ascorbic acid which occurs due to swimming stress. 
 
iii. Anti-ulcerogenic effect 
 
Ashwagandha was found to be useful in the prevention of stress-induced ulcers of the gastrointestinal tract (Singh 
et al. 1982). It showed significant protection against 18 h immobilization, cold + immobilization (4h) and aspirin induced 
gastric ulcers and lowered the mean ulcer index in rats. 
 
iv. Effect on leucocytosis 
  
Ashwagandha given to a group of mice with milk injection produced reduction in leucocytosis. 
 
v. Anabolic effects: 
 
There was a significant increase in the body weights of the Ashwagandha treated group as compared to control for 
a period of 3 months in rats. 
 
Acute toxicity studies 
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Anti-tumor effect 
Effect on Chinese Hamster Ovary (CHO) cells carcinoma 
 
 Withania roots caused the inhibitory effect of about 49% on colony forming efficiency of CHO cells. It inhibits the 
cell growth and prevents the cell attachment. It induced long term growth inhibition of CHO cells which was dependent on 
the cell density and duration of Ashwagandha exposure (Sumantran et al., 2007). This knowledge in turn will assist 
oncologists who plan to use the Ashwagandha as ‘synergizers with conventional chemotherapy or radiation therapy. 
 
Effect on Urethane induced lung-adenoma in mice and other studies: 
 
Ashwagandha was found to be very useful in experimental carcinogenesis in the crude form. It prevented urethane-
induced lung-adenomas in mice. The other effects of urethane like leucopoenia were also prevented. Urethane, which is a 
chemical stressor, causes variety of ill effects, all of which were prevented by Withania. The drug can be used as an adjunct 
to cancer chemotherapy or radiotherapy. Besides having an anti-cancer effect it will also reduce the side effects of anti-cancer 
agents, which invariably reduce immunity and quality of life. WS also acts as an immunomodulator and hence can enhance 
life span of cancer patients, where lowered immunity states of the patient are the cause of concern. Our results suggest its use 
as anti-tumor (Singh et al. 1979, 1981, 1986, 2010) and immunomodulator agent (Dixit et al., 1995). 
The research and studies of Ashwagandha’s activities in the inhibition and reduction of tumour growth have shown 
encouraging evidence that this remarkable herb may prove to be extremely effective in the treatment of tumor type diseases 
including cancer (Singh and Gilca, 2010). It also improves the white cell count (WBC) and function, which are depleted in 
the chemotherapeutic treatment of cancer. Ashwagandha in the treatment of fibroid tumors of the uterus showed reduction of 
uterine bleeding tendencies and disappearance of fibroids after long treatment (Abbas et al. 2004, 2005). 
 
Effect on Central Nervous System 
Cognition Promoting Effect 
 
Ashwagandha is a well known Ayurvedic Rasayana, and belongs to a sub-group of Rasayanas known as 
Medhyarasayanas. Medhya typically refers to the mind and mental/intellectual capacity. Thus, Medhya Rasayana like 
Ashwagandha, is used to promote intellect and memory.  The cognition-promoting effect of Medhya Rasayanas is best seen in 
children with memory deficits, or when memory is compromised following head injury, or a prolonged illness and in old age 
(Singh and Udupa., 1993).  
 
Effect on neurodegenerative diseases such as Parkinson’s, Huntington’s and Alzheimer’s diseases 
 
In patients with Alzheimer’s disease, neuritic atrophy and synaptic loss (Dickon and Vicker, 2001)  are considered 
the major causes of cognitive impairment, as based on the results of neuropathological post-mortem studies of the brain 
(Dekosky & Scheff, 1990). In the brains of patients suffering from other neurodegenerative diseases such as Parkinson’s 
disease, Huntington’s disease, and Creutzfeldt– Jakob disease, the atrophy of neurites has also been observed as a significant 
part of the etiology. There are dozens of studies that show that Ashwagandha slows, stops, reverses or removes neuritic atrophy 
and synaptic loss. Therefore Ashwagandha can be used to treat Alzheimer’s, Parkinson’s, Huntington’s and other 
neurodegenerative diseases at any stage of the disease, even before a person has been diagnosed and is still in the state of mild 
forgetfulness, etc. Glycowithanolides withaferin- A and sitoindosides VII-X isolated from the roots of Ashwagandha 
significantly reversed ibotenic acid induced cognitive defects in Alzheimer’s disease model (Bhattacharya et al., 1995).   
Ashwagandha has been described as a nervine tonic (Singh et al., 1988, 1993) in Ayurveda and that is why it is a common 
ingredient of Ayurvedic tonic. Tonics, rejuvenators and vitalizers of Ayurveda appear to allay disease and induce immunity 
(Singh et al., 1986) and longevity in the users.  
Pretreatment with Ashwaganda extract was found to prevent all the changes in antioxidant enzyme activities, 
catecholamine content, dopaminergic D2 receptor binding and tyrosine hydroxylase expression induced by 6-
hydroxydopamine (6-OHDA) in rats (an animal model of  Parkinson's disease) in a dose-dependent manner. Thus, these 
results suggest that Ashwagandha may be helpful in protecting the neuronal injury in Parkinson's disease (Nagashyana et al., 
2000). 
 
GABA-mimetic effect on neurodegeneration and neuroregenerative potential 
 
Behavioral experiments have lent support to the GABA-mimetic activity of Ashwagandha root extract. GABAergic 
neurodegeneration due to neuroleptic-induced excitotoxicity and oxidative stress is one of the etiopathological mechanisms in 
the pathophysiology of tardive dyskinesia (Gunne et al., 1993) and GABA agonists are shown to be effective in ameliorating 
the symptoms of tardive dyskinesia. The beneficial effect of Ashwagandha root extract might be due to its GABA mimetic 
activity.  Ashwagandha, its constituents and the metabolites of its constituents promote the growth of nerves after taking it for 7 
days. 
 An intriguing study demonstrated that chronic oral administration of withanoside IV attenuated the axonal, dendritic 
and synaptic losses and memory deficits induced by amyloid peptide Aβ(25-35) in mice (Kuboyama et al, 2006). After oral 
administration in mice, withanoside IV was metabolized into sominone, which induced marked recovery in neurites and 
synapses and also enhanced axonal and dendritic outgrowth and synaptogenesis. These effects were maintained for at least 7 
days after discontinuing withanoside IV administration. These data suggest that withanoside IV, and its metabolite, sominone, 
may have clinical usefulness as antidementia drugs. 
Another team found that the methanol extract of Ashwagandha  (5 mg/ml) significantly increased the percentage of 
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cells with neurites in human neuroblastoma SK-N-SH cells. The effect of the extract was dose-and time-dependent. mRNA 
levels of the dendritic markers MAP2 and PSD-95 by RT-PCR were found to be markedly increased by treatment with the 
extract. Immunocytochemistry demonstrated the specific expression of MAP2 in neurites extended by the extract. These results 




Ashwagandha induced a calming anxiolytic effect that was comparable to the drug Lorazepam in all three standard 
Anxiety tests: the elevated plus-maze, social interaction and the feeding latency in an unfamiliar environment. Further, both 
Ashwagandha and Lorazepam, reduced rat brain levels of tribulin, an endocoid marker of clinical anxiety, when the levels were 
increased following administration of the anxiogenic agent, pentylenetetrazole. 
Ashwagandha also exhibited an antidepressant effect, comparable with that induced by imipramine, in two standard 
tests, the forced swim-induced 'behavioral despair' and 'learned helplessness' tests. The investigations support the use of 
Ashwagandha as a mood stabilizer in clinical conditions of anxiety and depression. (Abdel-Magied et al., 2001) 
 
Effect on Energy levels and Mitochondrial Health: 
 
The effect of Ashwagandha on glycosaminoglycan synthesis in the granulation tissue of carrageenin-induced air 
pouch granuloma was studied. Ashwagandha is shown to exert significant inhibitory effect on incorporation of ribosome -35S 
into the granulation tissue. The uncoupling effect on oxidative phosphorylation (ADP/O ratio reduction) was also observed in 
the mitochondria of granulation tissue. Further, Mg2+ dependent ATPase activity was found to be influenced by 
Ashwagandha. Ashwagandha also reduced the succinate dehydrogenase enzyme activity in the mitochondria of granulation 
tissue (Begum & Sadique, 1987). 
 
Anti-inflammatory effect due to Withaferin: 
 
Withaferin A and 3-b-hydroxy-2,3-dihydrowithanolide F isolated from Withania  somnifera show promising 
antibacterial, antitumoral, immunomodulating and anti-inflammatory properties (Budhiraja and Sudhir, 1987).  
 
Anti-arthritic effect:  
 
Ashwagandha is an analgesic that soothes nervous system from pain response (Twajj et al., 1989). The powerful 
anti-arthritic properties (Singh et al. 1984, 1986) of Ashwagandha are now widely accepted and documented; it is 
furthermore found to be effective as antipyretic as well as analgesic also.   
Ashwagandha (1000 mg/kg/oral) produced significant analgesic activity for a rat experiencing heat analgesia induced 
by hot plate method. The peak analgesic effect of Ashwagandha was recorded as 78.03 percent at 2nd hour of administration. 
The involvement of pain mediators; prostaglandin and 5-hydroxytryptamine in analgesic activity of Ashwagandha was studied 
by pretreatment with paracetamol (100 mg/kg, ip) and cyproheptadine (10 mg/kg, ip). The analgesic activity of Ashwagandha 
was potentiated significantly by cyproheptadine, however, paracetamol failed to exhibit any significant change in its activity, 
suggesting the involvement of serotonin, but not prostaglandins in the analgesic activity of Ashwagandha (Mazen et al., 1990). 
 
 
Discussion and Conclusion  
 
The available scientific data support the conclusion that Ashwagandha is a real potent regenerative tonic (Rasayana 
of Ayurveda), due to its multiple pharmacological actions like anti-stress, neuroprotective, antitumor, anti-arthritic, analgesic 
and anti-inflammatory etc. It is useful for different types of diseases like Parkinson, dementia, memory loss, stress induced 
diseases, malignoma and others.   
Ashwagandha is used as a household remedy by Indians, who consider it as the best tonic for old people and 
children, and as aphrodisiac by young people. It is one of the best nervine tonics of Ayurveda, the most ancient system of 
Medical Sciences. Our clinical experience showed that besides the enumerated neurological conditions, brain strokes causing 
paralysis and neuronal deficit also improve in the long term treatment with Ashwagandha. We are also using it in all forms of 
cancer including prostate and lung cancers, especially in last stages, giving the patients lot of health benefits.  We have some 
cases of lung cancer who have refused modern therapy and recovered clinically and radiologically with our therapy of 
Ashwagandha. (Singh N., 2010- unpublished data). In a recent seminar (Singh, 2005) on essential drug concept, it was 
projected as one of the six essential medicinal herbs. 
Thus, the above findings clearly indicate that the traditional use of Ashwagandha has a logical and scientific basis. 
Large scale clinical studies are needed to prove the clinical efficacy of this herb, specially in stress related diseases, neuronal 
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